The company is developing a diabetes management system that optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies. They offer both automated infusion pump and connected insulin pen options for consumers, delivered via a monthly subscription service model. Bigfoot Biomedical aims to reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes by providing a comprehensive digital drug delivery platform experienced as a service.